Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Greenway Herbal Products LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner, PECKHAM, RICHARD GRANT, who is also the busiest examiner for the portfolio. With 1 busiest examiner pending action, the entire prosecution effort for the company is concentrated with this one individual at the patent office.
The portfolio is currently active in 1 distinct art unit, which indicates a very specific technical focus for the company's biotechnology innovations. Managing 1 pending office action is a streamlined process, as there is only 1 distinct examiner to engage with. This allows for a highly targeted prosecution strategy without the need to coordinate across different examination groups or technical classifications.
Practitioners should recognize that the presence of 1 distinct examiner means that the portfolio's progress depends on the assessment of PECKHAM, RICHARD GRANT. The focus on 1 distinct art unit simplifies the technical landscape for the pending application. With 1 pending office action, the company's immediate priority is to address the specific concerns of this single examiner to move the prosecution forward.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PECKHAM, RICHARD GRANT | 1 | 68.1% | +36.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19327713 | CANNABINOID COMPOSITIONS AND METHODS OF USING | PECKHAM, RICHARD GRANT | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19327713 | CANNABINOID COMPOSITIONS AND METHODS OF USING | PECKHAM, RICHARD GRANT | 1627 | §102§103§112DP | Final Rejection | — | Pending | Sep 12, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGreenway Herbal Products LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Richard Grant Peckham has the most, with 1 of Greenway Herbal Products LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
